The first experience of non-interferon therapy of HCV infection in patients with Wilson-Konovalov’s disease
- Authors: Rozina TP1,2, Ignatova TM1,2, Fastovets SV1,2, Starostina EE1, Samokhodskaia LM1, Krasnova TN1,2
-
Affiliations:
- Faculty of Medicine, M.V. Lomonosov Moscow State University
- I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 90, No 11 (2018)
- Pages: 74-78
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32905
- DOI: https://doi.org/10.26442/terarkh201890114-78
- ID: 32905
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T P Rozina
Faculty of Medicine, M.V. Lomonosov Moscow State University; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: alrozin@ya.ru
к.м.н., доцент фак-та фундаментальной медицины МГУ им. М.В. Ломоносова, https://orcid.org/0000-0001-5943-6181 Moscow, Russia
T M Ignatova
Faculty of Medicine, M.V. Lomonosov Moscow State University; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: tmignatova@gmail.com
д.м.н., проф. Moscow, Russia
S V Fastovets
Faculty of Medicine, M.V. Lomonosov Moscow State University; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: s.v.fastovets@gmail.com
аспирант фак-та фундаментальной медицины МГУ им. М.В. Ломоносова Moscow, Russia
E E Starostina
Faculty of Medicine, M.V. Lomonosov Moscow State University
Email: starostinaee@gmail.com
к.м.н., Медицинский научно-образовательный центр МГУ им. М.В. Ломоносова Moscow, Russia
L M Samokhodskaia
Faculty of Medicine, M.V. Lomonosov Moscow State University
Email: slm@fbm.msu.ru
к.м.н., доцент, Медицинский научно-образовательный центр МГУ им. М.В. Ломоносова Moscow, Russia
T N Krasnova
Faculty of Medicine, M.V. Lomonosov Moscow State University; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: krasnovamgu@yandex.ru
к.м.н., доцент фак-та фундаментальной медицины МГУ им. М.В. Ломоносова Moscow, Russia
References
- Scheinberg H, Sternlieb I, eds. Wilson’s disease. Philadelphia: WB Saunders; 1984.
- Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet. 2006;120:151-9. https://doi.org/10.1007/s00439-006-0202-5
- Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23:139-42.
- Stremmel W, Meyerrose K.W, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991;115:720-6.
- EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012; 56:671-85. https://doi.org/10.1016/j.jhep.2011.11.007
- Rodriguez-Castro K.I, Hevia-Urrutia F.H., Sturniolo G.C. Wilson’s disease: A review of what we have learned. World J Hepatol. 2015;7(29):2859-70. https://doi.org/10.4254/wjh.v7.i29.2859
- Dienstag J.L. Hepatitis B virus infection. N Engl J Med. 2008; 359(14):1486-500.
- Miriam J Alter. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-41.
- Chu N.S, Huang C.C. Wilson’s disease in Taiwan. Acta Neurol Taiwan. 2008;17(2):75-81.
- Deng H.H, Xu M. The clinical analysis of fulminant Wilson’s disease in patients with hepatitis B virus infection: a report of 13 cases. Zhonghua Nei Ke Za Zhi. 2016;55(8):628-30.
- Nalecz A, Socha J, Czlonkowska A, Gajda J. Wilson disease with HCV infections. Pediatr Pol. 1995;70(5):431-4.
- Lembowicz K, Kryczka W, Walewska-Zielecka B, Kubicka J. Wilson's disease coexisting with viral hepatitis type C: a case report with histological and ultrastructural studies of the liver. Ultrastruct Pathol. 1999;23(1):39-44.
- Розина Т.П., Рахимова О.Ю., Лопаткина Т.Н., Игнатова Т.М. Сочетание болезни Вильсона-Коновалова с хронической HCV-инфекцией (Клинико - морфологическое наблюдение). РЖГГК. 2004;14(2): 57-60.
- Manns M, Samuel D, Gane E.J, et al. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open - label, randomised, phase 2 trial. Lancet Infect Dis. 2016;16(6):685-97. https://doi.org/ 10.1016/S1473-3099(16)00052-9
Supplementary files
